Valuation: CellaVision AB

Market Cap 3.21B 333M 291M 269M 248M 468M 31.96B 476M 1.26B 15.65B 1.25B 1.22B 53.89B P/E 2026 *
23.5x
P/E 2027 * 18.8x
Enterprise Value 2.99B 310M 271M 251M 232M 436M 29.82B 444M 1.17B 14.6B 1.17B 1.14B 50.27B EV / Sales 2026 *
3.93x
EV / Sales 2027 * 3.47x
Free-Float
83.08%
Yield 2026 *
2.05%
Yield 2027 * 2.37%
1 day-2.89%
1 week-1.61%
Current month-1.32%
1 month-2.75%
3 months-10.76%
6 months-13.18%
Current year-14.50%
1 week 131.8
Extreme 131.8
139.8
1 month 131.8
Extreme 131.8
149.6
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.5
Extreme 70.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-12Buy 760 0.0032%
06-09Buy

Founder

33,000 0.1384%
06-09Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.89%-1.61%-25.00%-27.27% 341M
+0.20%+7.67%+18.99%-19.77% 17.68B
-0.94%-1.15%+12.91%+90.95% 1.65B
-1.29%+3.88%-38.81%-79.33% 1.22B
-3.09%-5.99%-34.90%+12.44% 1.06B
+3.56%+3.76%-28.27%-53.16% 616M
+0.65%+1.01%-38.78%-55.58% 554M
-2.13%-0.75%+33.29%-54.06% 455M
-2.21%-1.27%-55.23%-59.95% 385M
+2.64%+1.12%+21.43%+11.78% 301M
Average -0.55%+1.26%-13.44%-23.40% 2.43B
Weighted average by Cap. -0.10%+5.73%+9.30%-16.48%

Financials

2026 *2027 *
Net sales 760M 78.91M 68.96M 63.75M 58.9M 111M 7.58B 113M 298M 3.71B 296M 290M 12.78B 851M 88.29M 77.15M 71.32M 65.89M 124M 8.48B 126M 334M 4.15B 332M 324M 14.3B
Net income 136M 14.16M 12.37M 11.44M 10.57M 19.9M 1.36B 20.26M 53.51M 666M 53.17M 52M 2.29B 175M 18.16M 15.87M 14.67M 13.56M 25.53M 1.74B 25.99M 68.66M 854M 68.23M 66.72M 2.94B
Net Debt -215M -22.33M -19.52M -18.04M -16.67M -31.39M -2.15B -31.96M -84.41M -1.05B -83.88M -82.03M -3.62B -254M -26.35M -23.03M -21.29M -19.67M -37.03M -2.53B -37.71M -99.6M -1.24B -98.97M -96.79M -4.27B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
14/07/26 SEK 134.40 -2.89% 32,098
13/07/26 SEK 138.40 0.00% 21,004
10/07/26 SEK 138.40 +2.67% 12,538
09/07/26 SEK 134.80 +2.12% 16,039
08/07/26 SEK 132.00 -3.37% 32,326
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
134.40SEK
Average target price
171.25SEK
Spread / Average Target
+27.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock